Search

Rising AI and EV electricity demand, as well as growing exports, are fueling a natural gas boom and opening strong long-term opportunities across the energy sector.

The White House has recently published an Executive Order intended to permit alternative asset investment, including real estate, commodities and private equity, in retirement accounts and 401(k)s. This month, let’s take a closer look at private equity. We’ll explore how it works, how it performs relative to public investments you’re no doubt already familiar with, how you can add private equity exposure right now, and, most importantly, whether you should.

Just days after Netflix (NFLX) offered to acquire most of Warner Bros. Discovery (WBD), Paramount (PSKY) has made its own hostile bid. Here’s how it affects shareholders.

While people in the U.S. are familiar with Aflac, Inc.’s (AFL, NYSE) memorable (if not annoying) “duck” mascot, most Americans would likely be surprised to know that the company actually does most of its business in Japan. Aflac is the world’s largest underwriter of supplemental cancer insurance, with the largest...

If you’ve ever been tempted by the stories and claims about day trading – don’t be. Here’s why day trading isn’t something that we recommend at Cabot.

With growth stocks suffering, value and income are at a premium as we head into 2022. This emerging markets ETF provides both.

Facing the first sustained market downturn in their lifetimes, millennial investors have pulled back from investing and stopped “buying the dip.”

With the stock market regularly surging to record highs, it may seem like an unusual time to focus on valuation. After all, many stocks are remarkably expensive on traditional measures, and even somewhat lofty on non-traditional measures. But valuation still matters, especially if the market loses its current luster (assuming that is even possible)!

Despite a Chinese economy that has grown three times faster than America’s every year over the past three decades, it has been a bit of a challenge to consistently make money in Chinese stocks.

As expected, the market lost a little steam during the past few days, with buyers showing little interest after stocks ramped higher in previous weeks. Of course, the sellers aren’t showing much muscle, either, resulting in a short-term rotational, choppy environment. What about the long-term? Could the rally have already run its course? Sure, it’s always possible, especially given the stop-start environment since early 2011. But the evidence points to an intermediate-term (and longer-term) uptrend in the indexes and most stocks, so you should remain bullish. That doesn’t mean you can’t book a few partial profits on the way up, but you should also hold on to most of your best performers.

This week’s list has some different names, including a few that have recently strengthened after many months of idling. Our favorite of the week is Jazz Pharmaceuticals (JAZZ), a former small-cap leader of 2010 and 2011 that consolidated for the better part of a year before breaking out last week.

Stock Name	Price	Buy Range	Loss Limit
Computer Sciences (CSC)	0.00	31.5-33	-
Concur Technologies (CNQR)	0.00	72-74.5	-
Google Inc. (GOOG)	0.00	710-730	-
HCA Healthcare (HCA)	137.60	31-32	-
Jazz Pharmaceuticals (JAZZ)	0.00	54-58	-
Mellanox Technologies (MLNX)	92.00	104-108	-
MCO (MCO)	0.00	44-45	-
Phillips 66 (PSX)	0.00	45-47	-
Barrick Gold (GOLD)	27.20	114-119	-
Royal Gold, Inc. (RGLD)	129.66	90-95	-

This has been a busy week with earnings reports—the bulk of them on the positive side. China and other emerging and international companies seem to be posting good numbers but macro headwinds are weighing on markets for now.

The Hong Kong situation is one issue causing concern so this week we head back to Singapore for a high quality financial play on Asia

Reading the 10-K financial reports of the companies in which you’re invested seems boring and unnecessary. But it will surely make you a better investor.

The U.S.-China rivalry is closer than it’s ever been. How it evolves in the coming years will shape the global economy - and your portfolio.

Technology and Consumer Discretionary stocks will likely outperform other stocks during the early stages of the U.S. economic expansion.

We’ve talked here before about the importance of buying dividend-paying stocks at low prices in order to lock in high yields. (You can read the issue here if you missed it.) Recently, I read an interesting account on the importance of buying low in another way--based on P/E ratios. Steven...